Pt. Genero Pharmaceuticals is a finished-dose manufacturer based in Indonesia. It appears in 65 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with BPOM (ID) and SAHPRA (ZA). Its GMP standing is certified by BPOM (ID). Customs aggregates show $24 of exports covering 8 molecules to 1 destination in 2025.
| Site | FDA FEI |
|---|---|
| KAB. BEKASI, Indonesia | Not on file |
| -, Indonesia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| BPOM (ID) | 63 | 16 |
| SAHPRA (ZA) | 2 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $24 | 1 |
| 2024 | Not reported | $10 | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Pt. Genero Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free